loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people. .
viewpoint: china has the upper hand in cancer cell therapy
.more from the doncaster free press
.
lawmakers should revisit that idea when lepage is no longer in office next year. .